After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
292-G2) stimulates proliferation in the MCF-7 human breast cancer cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IGF-II/IGF2 (14 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IGF-II/IGF2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-292-NA). The ND50 is typically 0.2-0.8 µg/mL." class="big_lightbox" target="_blank">
792-MG) stimulates proliferation in the MCF-7 human breast cancer cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Mouse IGF-II/IGF2 (30 ng/mL) is neutralized (green line) by increasing concentrations of Mouse IGF-II/IGF2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF792). The ND50 is typically 0.5-2.5 µg/mL." class="big_lightbox" target="_blank">
792-MG) was serially diluted and captured by Rat Anti-Mouse IGF-II/IGF2 Monoclonal Antibody (Catalog # MAB792) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Mouse IGF-II/IGF2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF792) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998)" class="big_lightbox" target="_blank">